With almost a decade of senior agency experience at the Federal Trade Commission coupled with in-house experience at Amazon where she led M&A antitrust clearance strategy, Jasmine Rosner brings a unique perspective to all aspects of the merger review process. Her robust background has provided her the opportunity to work closely with regulatory regimes around the world, which is increasingly valuable given the growing trend towards multi-jurisdictional investigations.
During her time at the FTC, Jasmine was an Attorney Advisor to Commissioner Noah Phillips where she provided counsel on policy questions, merger challenges, and conduct investigations, including Edgewell/Harry’s, and Evonik/PeroxyChem, among others. Jasmine also served as counsel to three Directors of the Bureau of Competition where she advised on pending merger and conduct matters involving diverse legal questions such as buyer power, vertical mergers, failing firm defenses, so-called litigating the fix, state action doctrine, and potential and nascent competition. As a lead attorney in the FTC’s Mergers I Division, she spearheaded large investigations and negotiated numerous consent decrees, including Pfizer/Mylan, FTC v. Mallinckrodt, Teva/Allergan, and Thermo Fisher Scientific/Life Technologies, among others. Jasmine has also litigated in the FTC’s administrative court in FTC v. Benco Dental. She received the agency’s Catherine Moscatelli Mentoring Award for her leadership and mentorship of fellow staff attorneys at the Commission.